Cystic fibrosis (CF) is an autosomal recessive disorder affecting the cystic fibrosis transmembrane conductance regulator (CFTR) gene.1 Patients with CF have a mutated gene, resulting in defective CFTR proteins causing thick mucus in multiple body systems.2 CF mainly affects the lungs and the digestive systems in the body.2 At present there is no cure for CF, so the aims of treatment are to delay disease progression with lifelong pharmacological and non-pharmacological interventions.3 CF pharmacists are involved in medicines optimisation, antimicrobial stewardship and medication counselling to improve treatment adherence.
After successful completion of this CPD activity, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.3, 1.4, 2.1, 2.3, 2.4, 3.2
Extended learning activity
After additional reading and research from recommended resources, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.3, 1.4, 1.5, 2.2, 2.4, 3.1, 5.3
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS. Submit answers for the EXTENDED
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.